Korea Ginseng Corporation Report issue

For profit Phase 4
Founded: Seoul Korea, Republic of (1942)
Status: No NME R&D (1942)

Organization Overview

First Clinical Trial
2013
NCT02039635
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

Korea Ginseng Corporation

Active Ingredients

Drugs in Phase 4 Trials (1)

ginseng (3 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atherosclerosis (Phase 4)

Ischemia (Phase 4)

Stroke (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 1